329 related articles for article (PubMed ID: 22528787)
21. Protoporphyrin IX production and its photodynamic effects on glioma cells, neuroblastoma cells and normal cerebellar granule cells in vitro with 5-aminolevulinic acid and its hexylester.
Wu SM; Ren QG; Zhou MO; Peng Q; Chen JY
Cancer Lett; 2003 Oct; 200(2):123-31. PubMed ID: 14568165
[TBL] [Abstract][Full Text] [Related]
22. Physiological oxygen concentration alters glioma cell malignancy and responsiveness to photodynamic therapy in vitro.
Albert I; Hefti M; Luginbuehl V
Neurol Res; 2014 Nov; 36(11):1001-10. PubMed ID: 24923209
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic effects of 5-aminolevulinic acid and its hexylester on several cell lines.
Wu SM; Ren QG; Zhou MO; Wei Y; Chen JY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):655-60. PubMed ID: 12883637
[TBL] [Abstract][Full Text] [Related]
24. Accumulation of protoporphyrin-IX (PpIX) in leukemic cell lines following induction by 5-aminolevulinic acid (ALA).
Bartosová J; Hrkal Z
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jul; 126(3):245-52. PubMed ID: 11048674
[TBL] [Abstract][Full Text] [Related]
25. 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges.
Harada Y; Murayama Y; Takamatsu T; Otsuji E; Tanaka H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742921
[TBL] [Abstract][Full Text] [Related]
26. ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment.
Stepp H; Beck T; Pongratz T; Meinel T; Kreth FW; Tonn JCh; Stummer W
J Environ Pathol Toxicol Oncol; 2007; 26(2):157-64. PubMed ID: 17725542
[TBL] [Abstract][Full Text] [Related]
27. Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells.
Messmann H; Geisler M; Gross U; Abels C; Szeimies RM; Steinbach P; Knüchel R; Doss M; Schölmerich J; Holstege A
Br J Cancer; 1997; 76(7):878-83. PubMed ID: 9328146
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
[TBL] [Abstract][Full Text] [Related]
29. 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells.
Uehlinger P; Zellweger M; Wagnières G; Juillerat-Jeanneret L; van den Bergh H; Lange N
J Photochem Photobiol B; 2000 Jan; 54(1):72-80. PubMed ID: 10739146
[TBL] [Abstract][Full Text] [Related]
30. Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells.
Krieg RC; Messmann H; Rauch J; Seeger S; Knuechel R
Photochem Photobiol; 2002 Nov; 76(5):518-25. PubMed ID: 12462647
[TBL] [Abstract][Full Text] [Related]
31. Protoporphyrin IX fluorescence kinetics in C6 glioblastoma cells after delta-aminolevulinic acid incubation: effect of a protoporphyrinogen oxidase inhibitor.
Carre J; Eleouet S; Rousset N; Vonarx V; Heyman D; Lajat Y; Patrice T
Cell Mol Biol (Noisy-le-grand); 1999 Jun; 45(4):433-44. PubMed ID: 10432190
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
33. Characterization of plasma-derived protoporphyrin-IX-positive extracellular vesicles following 5-ALA use in patients with malignant glioma.
Jones PS; Yekula A; Lansbury E; Small JL; Ayinon C; Mordecai S; Hochberg FH; Tigges J; Delcuze B; Charest A; Ghiran I; Balaj L; Carter BS
EBioMedicine; 2019 Oct; 48():23-35. PubMed ID: 31628025
[TBL] [Abstract][Full Text] [Related]
34. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
Chandratre S; Olsen J; Howley R; Chen B
Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
[TBL] [Abstract][Full Text] [Related]
35. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.
Teng L; Nakada M; Zhao SG; Endo Y; Furuyama N; Nambu E; Pyko IV; Hayashi Y; Hamada JI
Br J Cancer; 2011 Mar; 104(5):798-807. PubMed ID: 21304523
[TBL] [Abstract][Full Text] [Related]
36. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
[TBL] [Abstract][Full Text] [Related]
37. 5-Aminolevulinic acid strongly enhances delayed intracellular production of reactive oxygen species (ROS) generated by ionizing irradiation: quantitative analyses and visualization of intracellular ROS production in glioma cells in vitro.
Kitagawa T; Yamamoto J; Tanaka T; Nakano Y; Akiba D; Ueta K; Nishizawa S
Oncol Rep; 2015 Feb; 33(2):583-90. PubMed ID: 25420428
[TBL] [Abstract][Full Text] [Related]
38. 5-Aminolevulinic acid-induced protoporphyrin IX levels in tissue of human malignant brain tumors.
Johansson A; Palte G; Schnell O; Tonn JC; Herms J; Stepp H
Photochem Photobiol; 2010; 86(6):1373-8. PubMed ID: 20854414
[TBL] [Abstract][Full Text] [Related]
39. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells.
Bissonnette R; Zeng H; McLean DI; Korbelik M; Lui H
Photochem Photobiol; 2001 Aug; 74(2):339-45. PubMed ID: 11547574
[TBL] [Abstract][Full Text] [Related]
40. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.
Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J
Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]